Explore

Insider trades Fund moves Congressional trades Federal contracts

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

Search/

Search/

Loading…

Regeneron Pharmaceuticals (REGN) insider trades, Congressional trades and 13F ownership | OQRO

Home
Insider trades
Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals

REGN · NASDAQ · Biotechnology

Follow REGN free

Overview Insider trades Federal contracts Fund moves Congress Lobbying & PAC News Timeline

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Next results expected Oct 30, 2026 (Q3 2026). Dates can move until the company confirms them.

From the company, last 60 days

Oct 6Signed an important agreement and Reported its earningsOfficial announcement, SEC filing (8-K)
Sep 30Changed a top manager or board memberOfficial announcement, SEC filing (8-K)

In the press, last 3 weeks

Oct 1Sanofi, Regeneron to Expand Alliance in Deal Valued at Up to $8 BillionThe Wall Street Journal
Sep 28Why This Regeneron Eye Rival Just Catapulted More Than 120%Investor's Business Daily
Sep 28Why Regeneron Rival Kodiak Sciences Just Skyrocketed 90%-PlusInvestor's Business Daily

Headlines link to the original article. Lists and “should you buy” pieces are left out. Coverage is not a recommendation.